From testing to treatment, the conversation around PARP inhibition in breast cancer is rapidly evolving.

In this episode, Dr. Neil Iyengar and Dr. Mark Robson explore how germline testing, risk stratification, and therapy sequencing are shaping adjuvant treatment decisions for BRCA1/2-mutated breast cancer.

They discuss:

🔹 Who should be tested — and how testing criteria are expanding.

🔹 Key takeaways from OlympiA and long-term data on olaparib.

🔹 The balance between PARP inhibitors, CDK4/6 inhibitors, and IO-based regimens.

🔹 How toxicity, sequencing, and emerging biomarkers like MRD may guide the future of adjuvant therapy.

Stay ahead of the data in this forward-looking conversation on personalizing care for high-risk HER2-negative breast cancer.

📺 Subscribe to Community Health Media and stream the full conversation on YouTube, Spotify, or your favorite podcast platform.

#CommunityHealthMedia #BreastCancerResearch #AdjuvantTherapy #PARPInhibitors #Olaparib #OlympiAStudy #BRCA #OncologyPodcast #BreastOncology #CancerCare #PrecisionOncology #OncologyEducation

–

Thanks for watching!

Our podcasts are also available on:

• Spotify - https://spotf.fi/chm-podcast

• Amazon Music - https://amazn.so/chm-podcast

• Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248

• Castbox - https://castbox.fm/vh/6735434

• Goodpods - https://goodpods.com/profile/chm-111066

• iHeartRadio - https://iheart.com/podcast/291542082

• Pocket Casts - https://pca.st/3ncdh11o

–

Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.

We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.

We specialize in:

• Peer to peer interviews, panels & round-tables

• Curated live events & conferences

• Professional in-depth content & research updates

• Interactive learning modules & webinars

• Live & on-demand webcasts & podcasts

Learn more about us here - https://communityhealth.media